http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014084333-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-445 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-015 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 |
filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2014084333-A1 |
titleOfInvention | Protozoan proteins involved in infection of the Plasmodium liver stage |
abstract | By identifying a protein essential for the malaria parasite of the liver infection stage to reach the next stage, providing a test method for searching for a compound that inhibits the protein, and inhibiting the protein, malaria It is an object to provide a compound that inhibits protozoan infection. By inhibiting the action of LS-specific protein 2 (LS-specific protein 2 (LISP2)), which is expressed in host cells during the middle to late stages of the liver infection stage, It is achieved by a method for testing a malaria parasite infection inhibitor characterized by evaluating whether or not it inhibits merozoite formation. [Selection] Figure 2 |
priorityDate | 2012-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 705.